M&A · Healthcare · Buyer's industry: Surgical & Medical Instruments & Apparatus
Haemonetics Corp to acquire OpSens Inc.
Announced Dec 12, 2023 · Closed Dec 12, 2023 · Private target
Deal value$255M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$2.90 per share
Transaction
- Acquirer
- Haemonetics Corp (HAE)
- Target
- OpSens Inc.
- Buyer type
- Strategic
- Offer price per share
- $2.90
- Enterprise value
- —
- Status
- Closed Dec 12, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Surgical & Medical Instruments & Apparatus